Happiness Biotech Started Exporting Disposable Hand Sanitizer

2020-04-08 20:00 2500

NANPING, China, April 8, 2020 /PRNewswire/ -- Happiness Biotech Group Limited (the "Company" or Nasdaq: HAPP), an innovative China-based nutraceutical and dietary supplements producer, announced today that the Company has received the CE certification from Istituto Servizi Europei Tecnologici ("ISET") for disposable hand sanitizer and started exporting this week. The first seven containers of 500,000 bottles of disposable hand sanitizer have been shipped to Malaysia, Australia and Poland.

The Company has been vigorously developing all kinds of epidemic prevention products including testing kits, masks and hand sanitizer, etc. since the outbreak of the COVID-19. As the pandemic becomes widely spread all over the world, the Company has been trying to obtain the qualification to export as well. On March 24, the Company obtained the CE certification for disposable hand sanitizer and was overloaded with orders from overseas since then. By April 8, all four production lines of disposable hand sanitizer were put into production, and the capacity has reached 200,000 bottles per day.

"As previously announced, we applied for CE certification in Europe and FDA certification in the U.S. for our epidemic prevention products. Obtaining the CE certification from ISET for disposable hand sanitizer is a great start and we expect to receive more certifications for our products in the near future. The COVID-19 has become a global disaster and caused a shortage of all kinds of supplies, especially prevention related materials. Again, as a public company in the U.S., we hope that we can be a part of the global efforts to combat this pandemic." said Mr. Xuezhu Wang, CEO of the Company.

About Happiness Biotech Group Limited

Headquartered in Nanping, China, Happiness Biotech Group Limited is an innovative China-based nutraceutical and dietary supplements producer focused on the research, development, manufacturing and marketing of a variety of products made from Chinese herbal extracts and other ingredients. The Company's goal is to provide high-quality products to our consumers. Over the past 14 years, the Company has established a product portfolio consisting of 32 CFDA registered "Blue-Cap" SKUs of nutraceutical and dietary supplements products. For more information, please visit:

Forward-Looking Statements

This press release contains forward-looking statements as defined by the Private Securities Litigation Reform Act of 1995. Forward-looking statements include statements concerning plans, objectives, goals, strategies, future events or performance, and underlying assumptions and other statements that are other than statements of historical facts. When the Company uses words such as "may, "will, "intend," "should," "believe," "expect," "anticipate," "project," "estimate" or similar expressions that do not relate solely to historical matters, it is making forward-looking statements. Forward-looking statements are not guarantees of future performance and involve risks and uncertainties that may cause the actual results to differ materially from the Company's expectations discussed in the forward-looking statements. These statements are subject to uncertainties and risks including, but not limited to, the following:  the Company's goals and strategies; the Company's future business development; product and service demand and acceptance; changes in technology; economic conditions; reputation and brand; the impact of competition and pricing; government regulations; fluctuations in general economic and business conditions in China, the COVID-19 outbreak and its impact on our operations and assumptions underlying or related to any of the foregoing and other risks contained in reports filed by the Company with the Securities and Exchange Commission.  For these reasons, among others, investors are cautioned not to place undue reliance upon any forward-looking statements in this press release. Additional factors are discussed in the Company's filings with the U.S. Securities and Exchange Commission, which are available for review at The Company undertakes no obligation to publicly revise these forward-looking statements to reflect events or circumstances that arise after the date hereof.

Cision View original content:

Source: Happiness Biotech Group Limited
Related Stocks:
Related Links: